National Institutes of Health
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, up to $600K, closing November 5, 2029.
Overview
Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor…